Sant Pau Memory Unit
“Excellence in care, research and innovation
in neurodegenerative diseases.”
+500
PUBLICATIONS
+60
RESEARCHERS
+20
YEARS OF RESEARCH
+300
INTERNATIONAL COLLABORATIONS
OUR RESEARCH ⬈
CLINICAL TRIALS ⬈
The unique composition of the Sant Pau Memory Unit has favored the development of translational research lines that combine clinical observation, direct contact with the people treated and their families, and basic research in the laboratory.
Our Memory Unit treats more than 2000 patients each year and is made up of a multidisciplinary team of professionals that includes specialists in neurology, neuropsychology, biology, engineering, laboratory technicians and research nursing staff. This multidisciplinary structure, unique in the State and exceptional in Europe, allows us to combine clinical and laboratory studies, positioning our team as a benchmark in the treatment and research of Alzheimer’s disease.
The Sant Pau Memory Unit of the Neurology Department at Hospital de la Santa Creu i Sant Pau in Barcelona is a multidisciplinary team dedicated to the assistance and research in Alzheimer and other neurodegenerative diseases.
Changes in serum β-synuclein precede blood biomarkers of Alzheimer pathology in Down syndrome
Synaptic dysfunction is one of the earliest processes involved in Alzheimer’s disease (AD) and is closely associated with cognitive decline. However, currently available blood biomarkers primarily reflect other pathological processes, such as amyloid and tau...
Digital cognitive assessment and blood biomarkers: two complementary perspectives for assessing Alzheimer’s disease
Digital cognitive assessment and blood biomarkers: two complementary perspectives for assessing Alzheimer’s disease Blood-based biomarkers are making it easier to detect biological changes associated with Alzheimer’s disease through a simple blood test. However, on...
Epilepsy increases following the onset of Alzheimer’s disease in adults with Down syndrome
A strong link between the onset of Alzheimer’s and epileptic seizures In adults with Down syndrome, the risk of developing Alzheimer’s disease is particularly high due to genetic factors. In this study, we focused on analyzing the natural history of...
